Treatment Response and Clinical Outcomes of Well-Differentiated (WD) High-Grade (HG) Neuroendocrine Tumors (NETs) to 177Lu-DOTATATE

被引：0
|
作者：
Coffman, Kelley [1 ]
Bodei, Lisa [1 ]
Le, Tiffany [1 ]
Choi, Ye [1 ]
Chou, Joanne [1 ]
Capanu, Marinela [1 ]
Dunphy, Mark [1 ]
Fox, Josef [1 ]
Grewal, Ravinder [1 ]
Reddy, Ryan [1 ]
Riedl, Christopher [1 ]
Schoder, Heiko [1 ]
Reidy-Lagunes, Diane [1 ]
Raj, Nitya [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
来源：
PANCREAS | 2022年 / 51卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
C-37
引用
收藏
页码：E46 / E46
页数：1
相关论文
共 50 条
  • [1] Treatment response and clinical outcomes of well-differentiated high-grade neuroendocrine tumors to 177Lu-DOTATATE.
    Coffman, Kelley Lauren
    Bodei, Lisa
    Le, Tiffany
    Choi, Ye
    Chou, Joanne F.
    Capanu, Marinela
    Dunphy, Mark
    Fox, Josef J.
    Grewal, Ravinder K.
    Reddy, Ryan
    Riedl, Christopher
    Schoder, Heiko
    Reidy, Diane Lauren
    Raj, Nitya Prabhakar
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03)
  • [2] Treatment Response and Clinical Outcomes of Well-Differentiated High-Grade Neuroendocrine Tumors to Lutetium-177-DOTATATE
    Raj, Nitya
    Coffman, Kelley
    Le, Tiffany
    Do, Richard Kinh Gian
    Rafailov, Johnathan
    Choi, Ye
    Chou, Joanne F.
    Capanu, Marinela
    Dunphy, Mark
    Fox, Josef J.
    Grewal, Ravinder K.
    Reddy, Ryan P.
    Riedl, Christopher
    Schoder, Heiko
    Bodei, Lisa
    Reidy-Lagunes, Diane
    [J]. NEUROENDOCRINOLOGY, 2022, 112 (12) : 1177 - 1186
  • [3] Treatment Outcomes of Well-Differentiated High-Grade Neuroendocrine Tumors
    Liu, Alex J.
    Ueberroth, Benjamin E.
    McGarrah, Patrick W.
    Buckner Petty, Skye A.
    Kendi, Ayse Tuba
    Starr, Jason
    Hobday, Timothy J.
    Halfdanarson, Thorvardur R.
    Sonbol, Mohamad Bassam
    [J]. ONCOLOGIST, 2021, 26 (05): : 383 - 388
  • [4] Treatment Outcomes of Well-Differentiated High-Grade Neuroendocrine Tumors
    Liu, A.
    Ueberroth, B.
    McGarrah, P.
    Petty, S. A. Buckner
    Kendi, A.
    Starr, J.
    Hobday, T.
    Halfdanarson, T. R.
    Sonbol, M. B.
    [J]. PANCREAS, 2021, 50 (03) : 448 - 448
  • [5] Validation of a Clinical Score (CS) for Patients With Well-Differentiated Neuroendocrine Tumors (WD NETs) Under Consideration for Peptide Receptor Radionuclide Therapy (PRRT) With 177Lu-Dotatate
    Das, Satya
    Chauhan, Aman
    Du, Liping
    Thomas, Katharine E.
    Jacob, Aasems
    Schad, Aimee
    Jain, Shikha
    Jessop, Aaron
    Shah, Chirayu
    Eisner, David
    Cardin, Dana B.
    Ciombor, Kristen K.
    Goff, Laura W.
    Bradshaw, Marques
    Delbeke, Dominique
    Sandler, Martin
    Berlin, Jordan
    Ramirez, Robert A.
    [J]. PANCREAS, 2022, 51 (03) : E41 - E41
  • [6] Survival predictors of 177Lu-Dotatate peptide receptor radionuclide therapy (PRRT) in patients with progressive well-differentiated neuroendocrine tumors (NETS)
    Swiha, Mina M.
    Sutherland, Duncan E. K.
    Sistani, Golmehr
    Khatami, Alireza
    Abazid, Rami M.
    Mujoomdar, Amol
    Wiseman, Daniele P.
    Romsa, Jonathan G.
    Reid, Robert H.
    Laidley, David T.
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2022, 148 (01) : 225 - 236
  • [7] Survival predictors of 177Lu-Dotatate peptide receptor radionuclide therapy (PRRT) in patients with progressive well-differentiated neuroendocrine tumors (NETS)
    Mina M. Swiha
    Duncan E. K. Sutherland
    Golmehr Sistani
    Alireza Khatami
    Rami M. Abazid
    Amol Mujoomdar
    Daniele P. Wiseman
    Jonathan G. Romsa
    Robert H. Reid
    David T. Laidley
    [J]. Journal of Cancer Research and Clinical Oncology, 2022, 148 : 225 - 236
  • [8] Report of 177Lu-DOTATATE Therapy in Patients with Well-differentiated Metastatic Neuroendocrine Tumors: A Single Center Experience
    Abiodun-Ojo, Olayinka
    Shaib, Walid
    Fourzali, Yamil
    Rupji, Manali
    Switchenko, Jeffrey
    Muzahir, Saima
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2022, 63
  • [9] 177Lu-DOTATATE for the treatment of gastroenteropancreatic neuroendocrine tumors
    Das, Satya
    Al-Toubah, Taymeyah
    El-Haddad, Ghassan
    Strosberg, Jonathan
    [J]. EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2019, 13 (11) : 1023 - 1031
  • [10] Combined use of 177Lu-DOTATATE peptide receptor radionuclide therapy and fluzoparib for treatment of well-differentiated neuroendocrine tumors: A preclinical study
    Fu, Jingjing
    Qiu, Fan
    Stolniceanu, Cati Raluca
    Yu, Fei
    Zang, Shiming
    Xiang, Yili
    Huang, Yue
    Matovic, Milovan
    Stefanescu, Cipriana
    Tang, Qiyun
    Wang, Feng
    [J]. JOURNAL OF NEUROENDOCRINOLOGY, 2022, 34 (04)
12345